Intercept Pharmaceuticals is a biotech company focused on developing and commercializing novel therapeutics to treat chronic liver diseases. Obeticholic acid, or OCA, is an agonist of the farnesoid X receptor. Intercept Pharmaceuticals is a biotech company focused on developing and commercializing novel therapeutics to treat chronic liver diseases. Obeticholic acid, or OCA, is an agonist of the farnesoid X receptor.
MORRISTOWN, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc., a biopharmaceutical company and wholly owned subsidiary of Alfasigma S.p.A. focused on the development and...
sNDA intended to satisfy post-marketing requirements to confirm a clinical benefit in patients with PBCPrecedent-setting submission includes data from post-marketing studies COBALT and Study 401...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 19 | 19 | 19 | 0 | 0 | CS |
4 | 0 | 0 | 19 | 19 | 19 | 0 | 0 | CS |
12 | 0 | 0 | 19 | 19 | 19 | 0 | 0 | CS |
26 | 0 | 0 | 19 | 19 | 19 | 0 | 0 | CS |
52 | 8.67 | 83.9303000968 | 10.33 | 19.02 | 10.1 | 432653 | 18.60057293 | CS |
156 | 3.23 | 20.4819277108 | 15.77 | 21.86 | 8.8216 | 764312 | 15.70009389 | CS |
260 | -50.12 | -72.5115740741 | 69.12 | 125 | 8.8216 | 794232 | 28.20421523 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.